Home Biotech Stocks

Biotech Stocks

Random

Here’s Why Alkermes Plc Is Moving Now

ME Contributor - February 5, 2018

enGene Shines with a Host of Big Name Collaborations

CVS Health Corp (NYSE:CVS) Affirms Patient Care Ambitions With New Diabetes Program

Here’s A Near Term Opportunity In Oncology

Medtronic PLC (NYSE:MDT) Gets CE Mark For Deep Brain Stimulation Therapy Software

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX): A Discount Entry?

ME Contributor - February 28, 2017

AstraZeneca plc (ADR) (NYSE:AZN) Announces Sale Of Its Remaining Anaesthetics Drugs...

Andy Parker - September 15, 2017

Here’s What The AbbVie and Voyager Therapeutics Deal Really Means

ME Contributor - February 21, 2018

Did AbbVie Inc (NYSE:ABBV) Overpay For Stemcentrx In The $10 Billion...

Andy Parker - June 6, 2016

Weekly Biotech Report Part I – FDA To Decide On AstraZeneca...

David Rich - May 16, 2016

Answering The Important Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Questions

ME Contributor - March 8, 2017

This Company Could Be About To Disrupt A Million Patient Market

Jennifer Aldershot - November 18, 2015

NDA Watch: TherapeuticsMD Inc (NYSEMKT:TXMD) and Yuvvexy

ME Contributor - July 11, 2016

FDA Approves Medtronic plc (NYSE:MDT) Claria MRI Quad CRT-D SureScan

ME Contributor - November 15, 2016

AstraZeneca plc (ADR) (NYSE:AZN) In Respiratory Drug Deal With Circassia Pharmaceuticals

ME Contributor - March 20, 2017

12 3...146 Page 1 of 146

/* */

EDITOR PICKS

Market Morning: Brexit Bill Anger, Gilead Fights ICER, Big Apple Rots

September 11, 2020

Cases Mount, Plastic Bag Initiative, Mental Health Deteriorates, EU Socializes Borrowing...

July 22, 2020

Market Morning: S&P Says More Spending, Hong Kong Ping Pong, Riots,...

June 1, 2020

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.